Laparoscopic Adrenalectomy for Large Adrenal Tumors.
Is There Anything New in the Field of Large Adrenal Tumors ?
1 other identifier
observational
102
1 country
2
Brief Summary
Laparoscopic adrenalectomy is the treatment of choice for the benign tumor of less than 6 cm. However, this is an ongoing debate that exact cut-off value of tumor size for LA. The aim of this study was to assess whether the size of the adrenal tumor affects preoperative and postoperative outcomes in patients undergoing laparoscopic transperitoneal adrenalectomy as well as to evaluate the learning curve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedStudy Start
First participant enrolled
February 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2019
CompletedOctober 10, 2019
December 1, 2018
3 months
February 2, 2019
October 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Operation time
time from onset to complete of operation
intraoperative (minute)
Blood loss
amount of bleeding during surgery (milliliter)
intraoperative
hospitalization
duration of postoperative hospital stay
1 day
Complication
abnormal conditions during or after surgery
1 day
Study Arms (3)
Group 1
laparoscopic adrenalectomy group 1: tumor size as \< 6 (group1)
Group 2
Laparoscopic adrenalectomy group2: tumor size ≥ 6 cm (group2)
Learning Curve
The patients, underwent laparoscopic adrenalectomy, were also classified into group A (1-25), B (26-50), C (51-75), and D (76-102) according to the chronological order of their surgery in order to evaluate the learning curve.
Interventions
minimally invasive lateral transperitoneal adrenalectomy
Eligibility Criteria
From April 2010 to October 2018, preoperative and postoperative data of 107 patients who underwent laparoscopic adrenalectomy
You may qualify if:
- all hormonally active adrenal lesions,
- detection of increases in size in \< 4 cm adrenal tumors on serial imaging,
- solitary adrenal metastases without evidence of local invasion,
- tumors size ≥ 4 cm,
- patients between the age of 18 and 80
- American Society of Anesthesiologists score (ASA) ≤ 3.
You may not qualify if:
- suspicion of malignancy on imaging such as local invasion, irregular tumor margins
- Retroperitoneoscopic adrenalectomies
- laparoscopic partial adrenalectomies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Samsun Liv Hospitallead
- Ondokuz Mayıs Universitycollaborator
Study Sites (2)
Samsun Liv Hospital
Samsun, 55020, Turkey (Türkiye)
Ondokuz Mayıs University
Samsun, 55030, Turkey (Türkiye)
Related Publications (2)
Huynh KT, Lee DY, Lau BJ, Flaherty DC, Lee J, Goldfarb M. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma. J Am Coll Surg. 2016 Sep;223(3):485-92. doi: 10.1016/j.jamcollsurg.2016.05.015. Epub 2016 May 26.
PMID: 27238874BACKGROUNDConzo G, Gambardella C, Candela G, Sanguinetti A, Polistena A, Clarizia G, Patrone R, Di Capua F, Offi C, Musella M, Iorio S, Bellastella G, Pasquali D, De Bellis A, Sinisi A, Avenia N. Single center experience with laparoscopic adrenalectomy on a large clinical series. BMC Surg. 2018 Jan 11;18(1):2. doi: 10.1186/s12893-017-0333-8.
PMID: 29325527RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Şaban Sarıkaya, Prof. MD
Ondokuz Mayıs University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 2, 2019
First Posted
February 5, 2019
Study Start
February 7, 2019
Primary Completion
May 20, 2019
Study Completion
July 5, 2019
Last Updated
October 10, 2019
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share